Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × liposomal doxorubicin × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 5 Fallopian Tube Neoplasms 5 Breast Neoplasms 4 Sarcoma 3 Neoplasms 3 Neoplasm Metastasis 3 Multi-centric Castleman's Disease 2 Triple Negative Breast Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1 Recurrence 1 Peritoneal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphadenopathy 1 Lung Neoplasms 1 Low Grade Serous Ovarian Cancer 1 Liposarcoma 1 Leukemia-Lymphoma, Adult T-Cell 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Hodgkin Disease 1 Histiocytoma, Malignant Fibrous 1

Interventions

pembrolizumab 12 Specimen Handling 8 Nivolumab 8 Gemcitabine 8 Magnetic Resonance Spectroscopy 7 Carboplatin 7 enfortumab vedotin 6 Cisplatin 6 Docetaxel 5 sacituzumab govitecan 4 atezolizumab 3 Taxes 3 Paclitaxel 3 Ipilimumab 3 erdafitinib 2 durvalumab 2 cabozantinib 2 avelumab 2 Radiosurgery 2 Platinum 2 CTLA-4 Antigen 2 zanidatamab 1 veliparib 1 urelumab 1 tremelimumab 1 tislelizumab 1 tazemetostat 1 sapanisertib 1 relatlimab 1 olaparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡